48
Participants
Start Date
April 30, 2014
Primary Completion Date
December 27, 2018
Study Completion Date
December 27, 2018
Human-cl rhFVIII
UC Davis Medical Center, Sacramento
Sahyadri Speciality Hospital, Pune
Christian Medical College, Vellore
University of Alberta, Edmonton
Hospital for Sick Children, Toronto
Hopital de la Timone, Marseille
Hôpital Kremlin Bicètre, Paris
Institute of Hematology and Transfusiology, Tbilisi
IMSP Mother and Child Institute, Chisinau
University Medical School, Warsaw
"The National Children Specialized Hospital OHMATDET", Kiev
Danylo Halytsky Lviv National Medical University, Lviv
BC Children's Hospital, Vancouver
McMaster Children's Hospital, Hamilton
Great Ormond Street Hospital for Children, London
Lead Sponsor
Octapharma
INDUSTRY